Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen α (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2

被引:48
|
作者
Catusse, J [1 ]
Liotard, A [1 ]
Loillier, B [1 ]
Pruneau, D [1 ]
Paquet, JL [1 ]
机构
[1] Lab Fournier SA, Grp Pharmacochim Recepteurs, F-21121 Daix, France
关键词
G protein-coupled receptor; binding; activation; CXCL8; CXCL1; SB; 225002;
D O I
10.1016/S0006-2952(02)01619-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neutrophil recruitment to inflammatory sites is mediated by two related receptors: CXC chemokine receptors I (CXCR1) and 2 (CXCR2). Both receptors share two ligands, interleukin-8 (CXCL8) and GCP-2 (CXCL6), whereas several chemokines, including growth related oncogen alpha (CXCL 1) and a non-peptide antagonist (SB 225002) are specific for CXCR2. The objective of this study was to map the different amino acids involved in the binding and activation/inhibition of human CXCR2. This was performed by exchanging non-conserved amino acids of CXCR2 with their counterparts in CXCR1. The mutants generated showed that: (a) for CXCL8 binding, the N-terminus of CXCR1 and the second extra-cellular loop of CXCR2 are determinant, the N-terminus of CXCR2 is not sufficient and the transmembrane domain seven is probably involved; (b) for CXCL1, the N-terminus of CXCR2 is necessary but not Sufficient for binding. The activation study indicated that amino acids critical for activation are not necessarily involved in binding process. Finally, the mechanism of binding of a non-peptide antagonist on CXCR2 was investigated: it Occurred through epitopes (a) which were disseminated within the receptor, (b) which differed according to the use of CXCL8 or CXCL1 as a competitor and (c) which did not necessarily overlap with agonist binding sites. We also showed that inhibition of binding and inhibition of activation involved different amino acids. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:813 / 821
页数:9
相关论文
共 34 条
  • [1] Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen α (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2 (vol 65, pg 813, 2003)
    Catusse, J
    Liotard, A
    Loillier, B
    Pruneau, D
    Paquet, JL
    BIOCHEMICAL PHARMACOLOGY, 2003, 65 (11) : 1915 - 1916
  • [2] Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties
    Vacchini, Alessandro
    Mortier, Anneleen
    Proost, Paul
    Locati, Massimo
    Metzemaekers, Mieke
    Borroni, Elena Monica
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (12)
  • [3] The role of interleukin-8 (CXCL8) and CXCR2 in acquired chemoresistance of human colorectal carcinoma cells HCT116
    Dabkeviciene, Daiva
    Jonusiene, Violeta
    Zitkute, Vilmante
    Zalyte, Egle
    Grigaitis, Pranas
    Kirveliene, Vida
    Sasnauskiene, Ausra
    MEDICAL ONCOLOGY, 2015, 32 (12)
  • [4] The role of interleukin-8 (CXCL8) and CXCR2 in acquired chemoresistance of human colorectal carcinoma cells HCT116
    Daiva Dabkeviciene
    Violeta Jonusiene
    Vilmante Zitkute
    Egle Zalyte
    Pranas Grigaitis
    Vida Kirveliene
    Ausra Sasnauskiene
    Medical Oncology, 2015, 32
  • [5] Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2
    Casilli, F
    Bianchini, A
    Gloaguen, I
    Biordi, L
    Alesse, E
    Festuccia, C
    Cavalieri, B
    Strippoli, R
    Cervellera, MN
    Di Bitondo, R
    Ferretti, E
    Mainiero, F
    Bizzarri, C
    Colotta, F
    Bertini, R
    BIOCHEMICAL PHARMACOLOGY, 2005, 69 (03) : 385 - 394
  • [6] Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8
    Fan, Xuedong
    Patera, Andriani C.
    Pong-Kennedy, Amy
    Deno, Gregory
    Gonsiorek, Waldemar
    Manfra, Denise J.
    Vassileva, Galya
    Zeng, Ming
    Jackson, Craig
    Sullivan, Lee
    Sharif-Rodriguez, Wanda
    Opdenakker, Ghislain
    Van Damme, Jo
    Hedrick, Joseph A.
    Lundell, Daniel
    Lira, Sergio A.
    Hipkin, R. William
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (16) : 11658 - 11666
  • [7] Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2
    Heidemann, J
    Ogawa, H
    Dwinell, MB
    Rafiee, P
    Maaser, C
    Gockel, HR
    Otterson, MF
    Ota, DM
    Lügering, N
    Domschke, W
    Binion, DG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (10) : 8508 - 8515
  • [8] The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer
    Yamamoto, Yurie
    Kuroda, Kenji
    Sera, Tomohiro
    Sugimoto, Atsushi
    Kushiyama, Shuhei
    Nishimura, Sadaaki
    Togano, Shingo
    Okuno, Tomohisa
    Yoshii, Mami
    Tamura, Tatsuro
    Toyokawa, Takahiro
    Tanaka, Hiroaki
    Muguruma, Kazuya
    Ohira, Masaichi
    Yashiro, Masakazu
    ANTICANCER RESEARCH, 2019, 39 (12) : 6645 - 6652
  • [9] FUNCTIONAL ACTIVITY OF CXCL8 RECEPTORS, CXCR1 AND CXCR2, ON HUMAN MALIGNANT MELANOMA PROGRESSION
    Gabellini, C.
    Trisciuoglio, D.
    Desideri, M.
    Candiloro, A.
    Ragazzoni, Y.
    Orlandi, A.
    Zupi, G.
    Del Bufalo, D.
    CYTOMETRY PART A, 2010, 77A (02) : 196 - 197
  • [10] Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression
    Gabellini, Chiara
    Trisciuoglio, Daniela
    Desideri, Marianna
    Candiloro, Antonio
    Ragazzoni, Ylenia
    Orlandi, Augusto
    Zupi, Gabriella
    Del Bufalo, Donatella
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (14) : 2618 - 2627